Science, Protein Engineering, Molecular Biology, Biochemistry, Virtual Reality.
She noted her company’s experience with its monoclonal antibody, VX15 (pepinemab), in blocking the molecule. Chief Experience Officer Edgardo and Alessandro Monge of the Nanome Team Spheryx, Inc. introduced its new particle characterization instrument, xSight, at PepTalk. xSight implements